Clinical Trials Browser

Phase 2 × Advanced Esophagus Cancer × tyrosyl-glutamyl-tryptophan × Clear all

NCT03542422 2018-06-14

Apatinib as First -Line Treatment for Advanced Esophagus Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Esophagus Cancer